iBio, Inc. Statistics
Total Valuation
iBio, Inc. has a market cap or net worth of $15.16 million. The enterprise value is $28.97 million.
| Market Cap | 15.16M |
| Enterprise Value | 28.97M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
iBio, Inc. has 8.52 million shares outstanding. The number of shares has increased by 278.78% in one year.
| Shares Outstanding | 8.52M |
| Shares Change (YoY) | +278.78% |
| Shares Change (QoQ) | +54.87% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 26.90% |
| Float | 2.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 315.06 |
| Forward PS | n/a |
| PB Ratio | 1.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 579.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 1.88.
| Current Ratio | 0.91 |
| Quick Ratio | n/a |
| Debt / Equity | 1.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -242.61 |
Financial Efficiency
Return on equity (ROE) is -197.80% and return on invested capital (ROIC) is -78.33%.
| Return on Equity (ROE) | -197.80% |
| Return on Assets (ROA) | -69.40% |
| Return on Capital (ROIC) | -78.33% |
| Revenue Per Employee | $1,923 |
| Profits Per Employee | -$1.05M |
| Employee Count | 26 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.48% in the last 52 weeks. The beta is -3.52, so iBio, Inc.'s price volatility has been lower than the market average.
| Beta (1Y) | -3.52 |
| 52-Week Price Change | -92.48% |
| 50-Day Moving Average | 1.64 |
| 200-Day Moving Average | 4.33 |
| Relative Strength Index (RSI) | 47.26 |
| Average Volume (30 Days) | 3,892,725 |
Short Selling Information
The latest short interest is 184,450, so 2.17% of the outstanding shares have been sold short.
| Short Interest | 184,450 |
| Short Previous Month | 59,323 |
| Short % of Shares Out | 2.17% |
| Short % of Float | 6.95% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, iBio, Inc. had revenue of $50,000 and -$27.28 million in losses. Loss per share was -$15.02.
| Revenue | 50,000 |
| Gross Profit | 50,000 |
| Operating Income | -20.73M |
| Pretax Income | -27.28M |
| Net Income | -27.28M |
| EBITDA | -25.95M |
| EBIT | -27.17M |
| Loss Per Share | -$15.02 |
Balance Sheet
The company has $4.06 million in cash and $17.27 million in debt, giving a net cash position of -$13.21 million or -$1.55 per share.
| Cash & Cash Equivalents | 4.06M |
| Total Debt | 17.27M |
| Net Cash | -13.21M |
| Net Cash Per Share | -$1.55 |
| Equity / Book Value | 9.20M |
| Book Value Per Share | 1.08 |
| Working Capital | -1.85M |
Cash Flow
In the last 12 months, operating cash flow was -$18.89 million and capital expenditures $2.35 million, giving a free cash flow of -$16.54 million.
| Operating Cash Flow | -18.89M |
| Capital Expenditures | 2.35M |
| Free Cash Flow | -16.54M |
| FCF Per Share | -$8.91 |
Margins
Gross margin is 100.00%, with operating and profit margins of -41,466.00% and -54,568.00%.
| Gross Margin | 100.00% |
| Operating Margin | -41,466.00% |
| Pretax Margin | -54,568.00% |
| Profit Margin | -54,568.00% |
| EBITDA Margin | -51,896.00% |
| EBIT Margin | -54,344.00% |
| FCF Margin | -33,086.00% |
Dividends & Yields
iBio, Inc. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -278.78% |
| Shareholder Yield | -278.78% |
| Earnings Yield | -173.20% |
| FCF Yield | -105.01% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 29, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
iBio, Inc. has an Altman Z-Score of -14.78 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.78 |
| Piotroski F-Score | 2 |